Trials / Completed
CompletedNCT02127164
Vacuum Assisted Therapy in Emergent Contaminated Abdominal Surgeries
Prospective Evaluation of Wound Management Using Vacuum Assisted Instillation Therapy in Emergent Contaminated Abdominal Surgeries
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- University of Arizona · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Emergent abdominal surgeries have very high rate of wound contamination due to exposure to bacteria from GI tract. There are several different approaches to wound management in these patients including wet-to-dry dressing or application vacuum assisted device on the wound. The investigators propose using the vacuum assisted device with Dakin's solution on patients undergoing emergency surgery for hollow viscus perforation installed immediately at the end of operation and remained there for the first 3 postoperative days, followed by delayed primary closure on postoperative day 4. The investigators believe this technique can achieve earlier wound closure, decrease patient discomfort, improve cost savings, and potentially standardize and revolutionize the investigators management of heavily contaminated wounds.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | "Veraflo" device, Dakin's solution | Veraflo device will be installed on the wound to create negative pressure after surgery. Dakin's solution will be instilled through this device into the wound at the regular intervals. |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2017-05-01
- Completion
- 2017-06-01
- First posted
- 2014-04-30
- Last updated
- 2024-01-30
- Results posted
- 2024-01-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02127164. Inclusion in this directory is not an endorsement.